Healthcare provider profile · identity verified

Aaron D Dam, M.D.

Family Practice · MEDFORD, OR · NPI 1851826937

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	570	156
Amlodipine Besylate	Amlodipine Besylate	348	101
Levothyroxine Sodium	Levothyroxine Sodium	344	90
Omeprazole	Omeprazole	301	89
Lisinopril	Lisinopril	271	79
Losartan Potassium	Losartan Potassium	216	64
Gabapentin	Gabapentin	208	61
Metoprolol Succinate	Metoprolol Succinate	181	51
Trazodone Hcl	Trazodone Hcl	180	50
Rosuvastatin Calcium	Rosuvastatin Calcium	164	48
Tamsulosin Hcl	Tamsulosin Hcl	152	47
Metformin Hcl Er	Metformin Hcl	148	46
Albuterol Sulfate Hfa	Albuterol Sulfate	117	42
Potassium Chloride	Potassium Chloride	110	34
Hydrochlorothiazide	Hydrochlorothiazide	102	36
Escitalopram Oxalate	Escitalopram Oxalate	100	21
Furosemide	Furosemide	99	31
Alendronate Sodium	Alendronate Sodium	98	30
Eliquis	Apixaban	94	26
Pravastatin Sodium	Pravastatin Sodium	91	20
Sertraline Hcl	Sertraline Hcl	89	26
Bupropion Xl	Bupropion Hcl	87	24
Metformin Hcl	Metformin Hcl	83	24
Pantoprazole Sodium	Pantoprazole Sodium	81	25
Duloxetine Hcl	Duloxetine Hcl	78	22
Metoprolol Tartrate	Metoprolol Tartrate	76	21
Famotidine	Famotidine	73	18
Allopurinol	Allopurinol	70	25
Telmisartan	Telmisartan	70	18
Clopidogrel	Clopidogrel Bisulfate	68	17
Mirtazapine	Mirtazapine	67	17
Alprazolam	Alprazolam	63	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	22
Spironolactone	Spironolactone	61	19
Glipizide Er	Glipizide	60	19
Lovastatin	Lovastatin	60	17
Meloxicam	Meloxicam	59	21
Venlafaxine Hcl Er	Venlafaxine Hcl	59	17
Fluoxetine Hcl	Fluoxetine Hcl	58	19
Simvastatin	Simvastatin	57	16
Oxycodone Hcl	Oxycodone Hcl	54	12
Tramadol Hcl	Tramadol Hcl	54	19
Chlorthalidone	Chlorthalidone	50	15
Estradiol	Estradiol	49	15
Valsartan	Valsartan	49	11
Carvedilol	Carvedilol	46	12
Montelukast Sodium	Montelukast Sodium	46	16
Prednisone	Prednisone	46	23
Atenolol	Atenolol	45	suppressed
Lamotrigine	Lamotrigine	44	suppressed
Ozempic	Semaglutide	43	11
Hydroxyzine Hcl	Hydroxyzine Hcl	41	13
Lorazepam	Lorazepam	41	11
Fluticasone Propionate	Fluticasone Propionate	38	17
Synthroid	Levothyroxine Sodium	38	suppressed
Sucralfate	Sucralfate	37	suppressed
Finasteride	Finasteride	35	11
Memantine Hcl	Memantine Hcl	34	suppressed
Jardiance	Empagliflozin	33	12
Glipizide	Glipizide	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Celecoxib	Celecoxib	31	12
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Topiramate	Topiramate	29	12
Trulicity	Dulaglutide	29	suppressed
Baclofen	Baclofen	28	13
Levetiracetam	Levetiracetam	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Ketoconazole	Ketoconazole	27	21
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	15
Buspirone Hcl	Buspirone Hcl	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Ibuprofen	Ibuprofen	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ondansetron Odt	Ondansetron	21	16
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Warfarin Sodium	Warfarin Sodium	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Nystatin	Nystatin	13	11
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Torsemide	Torsemide	12	suppressed
Zafirlukast	Zafirlukast	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Progesterone	Progesterone, Micronized	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error